Building Safer Medical Devices with Smarter Compliance Strategies
Discover how Advena supports medical device companies with technical file preparation, risk management, and biological evaluation services.
Safe and compliant medical devices depend on three regulatory pillars: thorough technical documentation, systematic risk management under ISO 14971, and biological evaluation of materials in contact with the human body. Together these form the core of any EU MDR, UKCA, or FDA submission and must be actively maintained throughout the device's commercial lifetime — not just completed once at launch.
Bringing a medical device to market is a journey—and not just a technical one. It's a regulatory marathon that demands detailed documentation, strategic risk management, and rigorous testing to prove your product is both effective and safe.
That’s where expert support becomes crucial. Advena Ltd offers a range of services to help manufacturers meet these regulatory demands efficiently and confidently. Let's look at three essential pillars of device compliance.
1. Technical File Compilation – Getting the Details Right
Your technical file is the foundation of your regulatory submission. It tells the full story of your device—from its intended use and design to clinical data and labeling.
Advena provides dedicated support with technical documentation and file compilation, helping ensure that your documentation is structured, complete, and fully aligned with EU MDR or UKCA requirements. This isn’t just about passing audits—it’s about building a robust, traceable foundation for your product lifecycle.
2. Risk Management That Goes Beyond the Basics
Risk management isn't a one-time task—it's an ongoing process. From initial design through post-market surveillance, every medical device needs a solid risk management strategy in place.
With Advena’s guidance, companies can implement risk management systems that comply with ISO 14971 and meet the expectations of regulators. It’s all about identifying hazards early, analyzing potential harm, and putting the right controls in place to protect patients and users.
3. Biological Evaluation for Biocompatibility and Safety
For any device that comes into contact with the human body, biocompatibility is key. Advena supports clients through biological evaluation processes, ensuring that devices are safe from a toxicological and biological perspective—an essential step for CE marking under MDR.
---
The takeaway? Strong documentation, proactive risk planning, and thorough testing aren’t just regulatory requirements—they’re what build safer, more successful devices. And with Advena by your side, you're never navigating these challenges alone.
Frequently Asked Questions
What is ISO 14971 and why is it required for medical devices?
ISO 14971 is the internationally recognised standard for the application of risk management to medical devices. It is referenced by EU MDR, ISO 13485, and the FDA, making it effectively mandatory for devices seeking CE marking, UKCA marking, or FDA clearance/approval. The standard requires manufacturers to identify hazards, estimate and evaluate risks, control risks to acceptable levels, and monitor residual risks throughout the product lifecycle.
What must a medical device technical file contain?
Under EU MDR Annex II, the technical documentation must include: device description and specification (including variants and accessories); design and manufacturing information; general safety and performance requirements; benefit-risk analysis; risk management file; product verification and validation evidence; clinical evaluation report (CER); and post-market surveillance plan. Annex III adds the post-market surveillance report and PSUR/PMCF plan.
What is biological evaluation for medical devices?
Biological evaluation assesses the potential for materials used in a medical device to cause adverse biological responses in patients or users. It is governed by the ISO 10993 series of standards and must consider the nature of the material, its duration and type of body contact, and any processing residuals. A Biological Evaluation Report (BER) is required as part of technical documentation for EU MDR and FDA submissions for devices with body contact.